EBS - Emergent Biosolutions, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.26 0.32 (3.46%) --- --- --- --- 0.32 (3.46%) 0.26 (2.86%) 0.26 (2.86%)

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.22
Diluted EPS:
-0.22
Basic P/E:
-43.5455
Diluted P/E:
-43.5455
RSI(14) 1m:
39.48
VWAP:
9.62
RVol:
0.65

Events

Period Kind Movement Occurred At

Related News